Inhibition of beta-amyloid-induced neurotoxicity by imidazopyridoindoles derived from a synthetic combinatorial library.

Alzheimer's disease is a progressive neurodegenerative disorder characterized by the deposit of amyloid fibrils in the brain that result from the self-aggregative polymerization of the beta-amyloid peptide (Abeta). Evidence of a direct correlation between the ability of Abeta to form stable aggregates in aqueous solution and its neurotoxicity has been reported. The cytotoxic effects of Abeta have been attributed to the aggregation properties of a domain corresponding to the peptide fragment Abeta25-35. In an effort to generate novel inhibitors of Abeta neurotoxicity and/or aggregation, a mixture-based synthetic combinatorial library composed of 23 375 imidazopyridoindoles was generated and screened for inhibition of Abeta25-35 neurotoxicity toward the rat pheochromocytoma PC-12 cell line. The effect of the identified lead compounds on Abeta25-35 aggregation was then evaluated by means of circular dichroism (CD) and thioflavin-T fluorescence spectroscopy. Their activity against Abeta1-42 neurotoxicity toward the PC-12 cell line was also determined. The most active imidazopyridoindoles inhibited both Abeta25-35 and Abeta1-42 neurotoxicity in the low- to mid-micromolar range. Furthermore, inhibition of the random coil to beta-sheet transition and self-aggregation of Abeta25-35 was observed by CD and fluorescence spectroscopy, supporting the relationship between inhibition of the Abeta aggregation process and neurotoxicity.

[1]  P. Camilleri,et al.  β‐Cyclodextrin interacts with the Alzheimer amyloid β‐A4 peptide , 1994 .

[2]  C. Barrow,et al.  Solution structures of beta peptide and its constituent fragments: relation to amyloid deposition. , 1991, Science.

[3]  C. Cotman,et al.  Possible Role of Apoptosis in Alzheimer's Disease , 1994, Annals of the New York Academy of Sciences.

[4]  W C Johnson,et al.  Protein secondary structure and circular dichroism: A practical guide , 1990, Proteins.

[5]  Carl W. Cotman,et al.  Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[6]  D. Kirschner,et al.  Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides. , 1990, Science.

[7]  R. Murphy,et al.  Solvent effects on self-assembly of beta-amyloid peptide. , 1995, Biophysical journal.

[8]  H. Mori,et al.  Rifampicin prevents the aggregation and neurotoxicity of amyloid beta protein in vitro. , 1994, Biochemical and biophysical research communications.

[9]  L. Iversen,et al.  Inhibition of PC12 cell redox activity is a specific, early indicator of the mechanism of beta-amyloid-mediated cell death. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[10]  P. Cutler,et al.  Hemin and related porphyrins inhibit β‐amyloid aggregation , 1997 .

[11]  M. Beal,et al.  An in vivo model for the neurodegenerative effects of beta amyloid and protection by substance P. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[12]  S. Blondelle,et al.  Novel, potent calmodulin antagonists derived from an all-D hexapeptide combinatorial library that inhibit in vivo cell proliferation: activity and structural characterization. , 2000, The journal of peptide research : official journal of the American Peptide Society.

[13]  Carl W. Cotman,et al.  In vitro aging of ß-amyloid protein causes peptide aggregation and neurotoxicity , 1991, Brain Research.

[14]  M. Mattson,et al.  beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[15]  A. Monji,et al.  The inhibitory effect of laminin 1 and synthetic peptides deduced from the sequence in the laminin α1 chain on Aβ40 fibril formation in vitro , 1998, Neuroscience Letters.

[16]  C. Behl,et al.  Hydrogen peroxide mediates amyloid β protein toxicity , 1994, Cell.

[17]  C. Cotman,et al.  Structure‐Activity Analyses of β‐Amyloid Peptides: Contributions of the β25–35 Region to Aggregation and Neurotoxicity , 1995 .

[18]  G. Cole,et al.  Vitamin E protects nerve cells from amyloid βprotein toxicity , 1992 .

[19]  S. Orrenius,et al.  Glucocorticoids activate a suicide process in thymocytes through an elevation of cytosolic Ca2+ concentration. , 1989, Archives of biochemistry and biophysics.

[20]  Claudio Soto,et al.  β-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: Implications for Alzheimer's therapy , 1998, Nature Medicine.

[21]  H. Levine,et al.  Thioflavine T interaction with synthetic Alzheimer's disease β‐amyloid peptides: Detection of amyloid aggregation in solution , 1993, Protein science : a publication of the Protein Society.

[22]  J. Seelig,et al.  Reversible random coil-beta-sheet transition of the Alzheimer beta-amyloid fragment (25-35). , 1994, Biochemistry.

[23]  L. Kiessling,et al.  A Strategy for Designing Inhibitors of β-Amyloid Toxicity* , 1996, The Journal of Biological Chemistry.

[24]  G. Forloni,et al.  Apoptosis mediated neurotoxicity induced by chronic application of beta amyloid fragment 25-35. , 1993, Neuroreport.

[25]  R. Houghten,et al.  All D‐amino acid hexapeptide inhibitors of melittin's cytolytic activity derived from synthetic combinatorial libraries , 1996, Journal of molecular recognition : JMR.

[26]  R. Houghten,et al.  Identification of Inhibitors of Melittin Using Nonsupport-bound Combinatorial Libraries (*) , 1996, The Journal of Biological Chemistry.

[27]  M. B. Brennan.  BRINGING BACK THE MEMORIES , 1997 .

[28]  J. Pettegrew,et al.  Chrysamine-G, a lipophilic analogue of Congo red, inhibits A beta-induced toxicity in PC12 cells. , 1998, Life sciences.

[29]  B. Yankner,et al.  Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[30]  R. Houghten,et al.  The Current Status of Heterocyclic Combinatorial Libraries. , 1997, Chemical reviews.

[31]  R A Houghten,et al.  "Libraries from libraries": chemical transformation of combinatorial libraries to extend the range and repertoire of chemical diversity. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[32]  R A Houghten,et al.  Rapid identification of high affinity peptide ligands using positional scanning synthetic peptide combinatorial libraries. , 1992, BioTechniques.

[33]  R A Houghten,et al.  Simplified procedure for carrying out simultaneous multiple hydrogen fluoride cleavages of protected peptide resins. , 2009, International journal of peptide and protein research.

[34]  C. Soto,et al.  Inhibition of Alzheimer's amyloidosis by peptides that prevent beta-sheet conformation. , 1996, Biochemical and biophysical research communications.

[35]  Bruce A. Yankner,et al.  Methodological variables in the assessment of beta amyloid neurotoxicity , 1992, Neurobiology of Aging.

[36]  R A Houghten,et al.  Mixture-based synthetic combinatorial libraries. , 1999, Journal of medicinal chemistry.

[37]  P. Lansbury.  In pursuit of the molecular structure of amyloid plaque: new technology provides unexpected and critical information. , 1992, Biochemistry.

[38]  C. Cotman,et al.  All-D-Enantiomers of β-Amyloid Exhibit Similar Biological Properties to All-L-β-Amyloids* , 1997, The Journal of Biological Chemistry.

[39]  L. Tjernberg,et al.  Arrest of -Amyloid Fibril Formation by a Pentapeptide Ligand (*) , 1996, The Journal of Biological Chemistry.

[40]  S. Sahasrabudhe,et al.  Two-hybrid system as a model to study the interaction of beta-amyloid peptide monomers. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[41]  R A Houghten,et al.  Peptide libraries: Determination of relative reaction rates of protected amino acids in competitive couplings , 1994, Biopolymers.

[42]  S. Pollack,et al.  Sulfonated dyes attenuate the toxic effects of β-amyloid in a structure-specific fashion , 1995, Neuroscience Letters.

[43]  L. Tjernberg,et al.  Controlling Amyloid β-Peptide Fibril Formation with Protease-stable Ligands* , 1997, The Journal of Biological Chemistry.

[44]  C. Cotman,et al.  Apoptosis is induced by beta-amyloid in cultured central nervous system neurons. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[45]  G. Cole,et al.  Effects of injected Alzheimer beta-amyloid cores in rat brain. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[46]  R. Houghten.  General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[47]  P. Fraser,et al.  Arresting amyloidosis in vivo using small-molecule anionic sulphonates or sulphates: implications for Alzheimer's disease , 1995, Nature Medicine.

[48]  H. Loh,et al.  Neuroblastoma Neuro2A cells stably expressing a cloned mu-opioid receptor: a specific cellular model to study acute and chronic effects of morphine. , 1995, Brain research. Molecular brain research.